NPM-ALK, CLTC-ALK, and SQSTM1-ALK translocations lead to ALK and STAT3 phosphorylation [207] with downstream oncogenic activation of the transcription factor STAT3, which enhances lymphoma cell proliferation and growth. The gene discussed is STAT3; the disease is lymphoma.